Sacubitril/valsartan: A novel angiotensin receptor-neprilysin inhibitor
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference40 articles.
1. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;New Engl J Med,2006
2. Heart failure: epidemiology and prevention in India;Mark;Natl Med J India,2010
3. Heart failure in India: the INDUS (INDia ukieri study) study;Chaturvedi;J Pract Cardiovasc Sci,2016
4. A randomized trial of intensive versus standard blood-pressure control;New Engl J Med,2015
5. SPRINT Study Research Group. SPRINT Trial Results: latest news in hypertension management;Cushman;Hypertension,2016
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran;Health Economics Review;2023-09-04
2. Drug Degradation Prediction, In Silico Toxicity Assessment and Development of Stability-Indicating, Quality by Design Enabled UFLC Method for Sacubitril-Valsartan;Russian Journal of Bioorganic Chemistry;2023-05-11
3. Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena;Journal of Diabetes;2023-04-19
4. Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies;Biomedicines;2023-04-07
5. ANGIOTENSIN RECEPTOR–NEPRILYSIN INHIBITORS (ARNI) AND TOLERABILITY IN HEART FAILURE PATIENTS – A RETROSPECTIVE OBSERVATIONAL STUDY FROM PRINCE SULTAN CARDIAC CENTRE;FARMACIA;2023-02-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3